Thus, our data consistently suggested that AREG expression in tumor stroma acts as an SASP‐associated independent predictor of prognosis, which is exploitable in stratifying the risk of disease relapse and clinical mortality of post‐treatment patients, and that AREG production by the stroma may have a causal role in tumor progression. Here, AREG is linked to neoplasm.